AbbVie said its Rinvoq showed superiority over the company’s previous bestselling drug Humira in a head-to-head trial. Results showed that 43% of patients compared to 22% of patients on Humira ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback